The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-[(4S)-5-[(1S)-1-(3-chlorophenyl)ethyl]-2-(2,4-dimethoxypyrimidin-5-yl)-3-isopropyl-6-oxo-4H-pyrrolo[3,4-d]imidazol-4-yl]benzonitrile ID: ALA5288152
Chembl Id: CHEMBL5288152
Max Phase: Preclinical
Molecular Formula: C29H27ClN6O3
Molecular Weight: 543.03
Associated Items:
Names and Identifiers Canonical SMILES: COc1ncc(-c2nc3c(n2C(C)C)[C@H](c2ccc(C#N)cc2)N([C@@H](C)c2cccc(Cl)c2)C3=O)c(OC)n1
Standard InChI: InChI=1S/C29H27ClN6O3/c1-16(2)35-25-23(33-26(35)22-15-32-29(39-5)34-27(22)38-4)28(37)36(17(3)20-7-6-8-21(30)13-20)24(25)19-11-9-18(14-31)10-12-19/h6-13,15-17,24H,1-5H3/t17-,24-/m0/s1
Standard InChI Key: HBCMUWSFAJQEHC-XDHUDOTRSA-N
Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 543.03Molecular Weight (Monoisotopic): 542.1833AlogP: 5.77#Rotatable Bonds: 7Polar Surface Area: 106.16Molecular Species: NEUTRALHBA: 8HBD: ┄#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): ┄#RO5 Violations (Lipinski): 2CX Acidic pKa: 12.19CX Basic pKa: 2.52CX LogP: 5.65CX LogD: 5.65Aromatic Rings: 4Heavy Atoms: 39QED Weighted: 0.29Np Likeness Score: -1.22
References 1. Zhang S, Lou J, Li Y, Zhou F, Yan Z, Lyu X, Zhao Y.. (2021) Recent Progress and Clinical Development of Inhibitors that Block MDM4/p53 Protein-Protein Interactions., 64 (15.0): [PMID:34286973 ] [10.1021/acs.jmedchem.1c00940 ]